Skip navigation

Immunomodulation of exopolysaccharide produced by Lacticaseibacillus rhamnosus ZFM216 in cyclophosphamide-induced immunosuppressed mice by modulating gut microbiota

Immunomodulation of exopolysaccharide produced by Lacticaseibacillus rhamnosus ZFM216 in cyclophosphamide-induced immunosuppressed mice by modulating gut microbiota

Chen, Lian, Wang, Dong ORCID logoORCID: https://orcid.org/0000-0001-5214-2973, Liu, Wei, Zhou, Shaobo ORCID logoORCID: https://orcid.org/0000-0001-5214-2973, Gu, Qing ORCID logoORCID: https://orcid.org/0000-0001-5214-2973 and Zhou, Tao (2024) Immunomodulation of exopolysaccharide produced by Lacticaseibacillus rhamnosus ZFM216 in cyclophosphamide-induced immunosuppressed mice by modulating gut microbiota. International Journal of Biological Macromolecules, 283 (Part 2):137619. ISSN 0141-8130 (Print), 1757-448X (Online) (doi:10.1016/j.ijbiomac.2024.137619)

[thumbnail of Author's Accepted Manuscript] PDF (Author's Accepted Manuscript)
48671 ZHOU_Immunomodulation_Of_Exopolysaccharide_Produced_By_Lacticaseibacillus_Rhamnosus_ZFM216_In_Cyclophosphamide-Induced_Immunosuppressed_Mice_(AAM)_2024.pdf - Accepted Version
Restricted to Repository staff only until 18 December 2025.
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (1MB) | Request a copy
[thumbnail of Published article (restricted)] PDF (Published article (restricted))
48671 ZHOU_Immunomodulation_Of_Exopolysaccharide_Produced_By_Lacticaseibacillus_Rhamnosus_ZFM216_In_Cyclophosphamide-Induced_Immunosuppressed_Mice_(VoR)_2024.pdf - Published Version
Restricted to Repository staff only

Download (12MB) | Request a copy

Abstract

This study investigated the immunoregulatory activity of exopolysaccharides (EPS) produced by Lacticaseibacillus rhamnosus ZFM216 in immunosuppressed mice induced by cyclophosphamide (CTX). The results showed that EPS treatment effectively improved the body weight, immune organ index and splenic lymphocyte proliferation. EPS also mitigated the damage of immune organs, restored intestinal morphology, and regulated the levels of serum hemolysin and cytokines (e.g. TNF-α, INF-γ and IL-10). EPS promoted the release of NO, TNF-α, IL-1β, and IL-6 in RAW 264.7 cells, however, such effect was inhibited in the presence of inhibitors of TLR4 and MAPKs signaling pathways-related proteins, confirming that EPS achieved the immunomodulation by activating these two signaling pathways. Additionally, EPS, as a prebiotic, effectively improved the diversity of microbial communities, regulated the relative abundance of dominant microbial communities, restored CTX-induced gut microbiota dysbiosis, and promoted the production of short chain fatty acids (SCFAs) in the gut of mice. Thus, immunoregulatory effect of EPS could be attributed to its good ability to modulate the gut microbiota. EPS produced by L. rhamnosus ZFM216 has promising application as an ingredient of functional foods due to its potent probiotic effect.

Item Type: Article
Uncontrolled Keywords: exopolysaccharides, gut microbiota, immunomodulatory effect
Subjects: Q Science > Q Science (General)
Q Science > QR Microbiology
R Medicine > R Medicine (General)
Faculty / School / Research Centre / Research Group: Faculty of Engineering & Science
Faculty of Engineering & Science > School of Science (SCI)
Last Modified: 22 Nov 2024 14:29
URI: http://gala.gre.ac.uk/id/eprint/48671

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics